吉祥寺北口システムが気になった記事をクリップしています。タイトルから元記事にリンクしています。タグは記事タイトルを形態素分析しています。たまにコメントをつけています。
vaccine
COVID-19 vaccines and adverse events of special interest: A multinational Global Vaccine Data Network (GVDN) cohort study of 99 million vaccinated individuals – ScienceDirect
19
(777)
99
(59)
Adverse
(3)
and
(3289)
cohort
(8)
COVID-
(431)
data
(834)
Events
(31)
Global
(340)
GVDN
(1)
Individuals
(9)
interest
(9)
Million
(111)
Multinational
(3)
Network
(399)
of
(3341)
ScienceDirect
(27)
Special
(29)
Study
(95)
Vaccinated
(4)
vaccine
(23)
Vaccines
(5)
Moderna Announces Positive Phase 1/2 Data from mRNA-1083, the Company’s Combination Vaccine Against Influenza and COVID-19
1083
(1)
19
(777)
Against
(130)
and
(3289)
Announces
(243)
Combination
(5)
Company
(158)
COVID-
(431)
data
(834)
from
(593)
Influenza
(2)
Moderna
(3)
mRNA
(12)
Phase
(18)
positive
(23)
the
(4365)
vaccine
(23)
Janssen COVID-19 Vaccine | FDA
19
(777)
COVID-
(431)
FDA
(79)
Janssen
(3)
vaccine
(23)
WHO recommends groundbreaking malaria vaccine for children at risk
at
(474)
children
(21)
for
(5179)
Groundbreaking
(4)
malaria
(3)
Recommends
(6)
Risk
(79)
vaccine
(23)
Who
(126)
Managing harmful vaccine content on YouTube
Content
(294)
harmful
(6)
Managing
(11)
on
(1868)
vaccine
(23)
YouTube
(1060)
FDA Approves First COVID-19 Vaccine | FDA
19
(777)
approves
(8)
COVID-
(431)
FDA
(79)
first
(345)
vaccine
(23)
Moderna Announces First Participant Dosed in Phase 1/2 Study of Its Quadrivalent Seasonal Flu mRNA Vaccine | Moderna, Inc.
Announces
(243)
Dosed
(1)
first
(345)
Flu
(3)
in
(2447)
Inc
(994)
ITS
(231)
Moderna
(3)
mRNA
(12)
of
(3341)
Participant
(1)
Phase
(18)
Quadrivalent
(1)
Seasonal
(2)
Study
(95)
vaccine
(23)
Novavax COVID-19 Vaccine Demonstrates 90
100
(663)
19
(777)
90
(85)
Against
(130)
and
(3289)
COVID-
(431)
Demonstrates
(8)
disease
(24)
efficacy
(6)
in
(2447)
Inc
(994)
IR
(631)
Moderate
(19)
Novavax
(1)
Phase
(18)
Prevent
(25)
rotection
(1)
Severe
(12)
site
(432)
Trial
(35)
vaccine
(23)
verall
(1)
Community-level evidence for SARS-CoV-2 vaccine protection of unvaccinated individuals | Nature Medicine
Community-level
(1)
Evidence
(30)
for
(5179)
Individuals
(9)
Medicine
(26)
Nature
(151)
of
(3341)
Protection
(172)
SARS-CoV-
(45)
unvaccinated
(1)
vaccine
(23)
VAERS | Vaccine Safety | CDC
CDC
(77)
Safety
(93)
vaccine
(23)
VAERS
(1)
Alleged Russian-backed PR firm tried to convince influencers to attack Pfizer vaccine – The Washington Post
alleged
(8)
Attack
(173)
convince
(1)
Firm
(20)
influencers
(6)
Pfizer
(9)
Post
(72)
PR
(544)
Russian-backed
(1)
the
(4365)
to
(3295)
tried
(3)
vaccine
(23)
Washington
(27)
WHO lists additional COVID-19 vaccine for emergency use and issues interim policy recommendations
19
(777)
Additional
(21)
and
(3289)
COVID-
(431)
Emergency
(30)
for
(5179)
Interim
(6)
issues
(108)
Lists
(9)
Policy
(102)
recommendations
(14)
Use
(177)
vaccine
(23)
Who
(126)
Joint CDC and FDA Statement on Johnson & Johnson COVID-19 Vaccine | CDC Online Newsroom | CDC
19
(777)
and
(3289)
CDC
(77)
COVID-
(431)
FDA
(79)
Johnson
(31)
Joint
(32)
Newsroom
(694)
on
(1868)
ONLINE
(554)
Statement
(118)
vaccine
(23)
AstraZeneca’s COVID-19 vaccine: EMA finds possible link to very rare cases of unusual blood clots with low blood platelets | European Medicines Agency
19
(777)
agency
(34)
AstraZeneca’s
(1)
Blood
(8)
Cases
(28)
clots
(1)
COVID-
(431)
EMA
(5)
European
(41)
Finds
(37)
Link
(153)
LOW
(32)
Medicines
(2)
of
(3341)
platelets
(1)
possible
(27)
rare
(3)
to
(3295)
unusual
(5)
vaccine
(23)
very
(18)
with
(1607)
Updates to our work on COVID-19 vaccine misinformation
19
(777)
COVID-
(431)
misinformation
(16)
on
(1868)
our
(245)
to
(3295)
Updates
(389)
vaccine
(23)
WORK
(165)
Pfizer and BioNTech Submit COVID-19 Vaccine Stability Data at Standard Freezer Temperature to the U.S. FDA | BioNTech
19
(777)
and
(3289)
at
(474)
BioNTech
(5)
COVID-
(431)
data
(834)
FDA
(79)
Freezer
(2)
Pfizer
(9)
Stability
(16)
Standard
(80)
Submit
(3)
temperature
(9)
the
(4365)
to
(3295)
vaccine
(23)
Pfizer and BioNTech Submit COVID-19 Vaccine Stability Data at Standard Freezer Temperature to the U.S. FDA | Pfizer
19
(777)
and
(3289)
at
(474)
BioNTech
(5)
COVID-
(431)
data
(834)
FDA
(79)
Freezer
(2)
Pfizer
(9)
Stability
(16)
Standard
(80)
Submit
(3)
temperature
(9)
the
(4365)
to
(3295)
vaccine
(23)
Pfizer and BioNTech Submit COVID-19 Vaccine Stability Data at Standard Freeze Temperature to the U.S. FDA | Pfizer
19
(777)
and
(3289)
at
(474)
BioNTech
(5)
COVID-
(431)
data
(834)
FDA
(79)
freeze
(2)
Pfizer
(9)
Stability
(16)
Standard
(80)
Submit
(3)
temperature
(9)
the
(4365)
to
(3295)
vaccine
(23)
Kroger Announces New Vaccine Payment for All Associates – The Kroger Co.
All
(263)
Announces
(243)
Associates
(7)
co
(725)
for
(5179)
Kroger
(2)
new
(1446)
Payment
(45)
the
(4365)
vaccine
(23)
Johnson & Johnson Announces Single-Shot Janssen COVID-19 Vaccine Candidate Met Primary Endpoints in Interim Analysis of its Phase 3 ENSEMBLE Trial | Johnson & Johnson
19
(777)
Analysis
(76)
Announces
(243)
Candidate
(18)
COVID-
(431)
Endpoints
(9)
ENSEMBLE
(2)
in
(2447)
Interim
(6)
ITS
(231)
Janssen
(3)
Johnson
(31)
Met
(4)
of
(3341)
Phase
(18)
Primary
(3)
Single-Shot
(1)
Trial
(35)
vaccine
(23)
Introducing Project Fair Shot: Ensuring COVID-19 Vaccine Registration Sites Can Keep Up With Demand
19
(777)
can
(241)
COVID-
(431)
Demand
(28)
Ensuring
(4)
Fair
(14)
Introducing
(480)
Keep
(49)
Project
(432)
Registration
(7)
shot
(10)
sites
(40)
up
(193)
vaccine
(23)
with
(1607)
UPDATE: ALBERT BOURLA DISCUSSES COVID-19 VACCINE EFFICACY RESULTS | Pfizer
19
(777)
ALBERT
(19)
BOURLA
(1)
COVID-
(431)
discusses
(2)
efficacy
(6)
Pfizer
(9)
Results
(66)
Update
(1095)
vaccine
(23)
WHO prequalifies Ebola vaccine, paving the way for its use in high-risk countries
Countries
(21)
Ebola
(4)
for
(5179)
high-risk
(1)
in
(2447)
ITS
(231)
paving
(3)
prequalifies
(1)
the
(4365)
Use
(177)
vaccine
(23)
way
(100)
Who
(126)